SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson… - Blood, The Journal …, 2020 - ashpublications.org
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson, E Papaemmanuil… - …, 2020 - pubmed.ncbi.nlm.nih.gov
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …

[HTML][HTML] Special Report: SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson, E Papaemmanuil… - Blood, 2020 - ncbi.nlm.nih.gov
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.

L Malcovati, K Stevenson, E Papaemmanuil… - Blood, 2020 - europepmc.org
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …

SF3B1-mutant MDS as a distinct disease subtype: A proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson… - …, 2020 - researchinformation.amsterdamumc …
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson, E Papaemmanuil… - Blood, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The 2016 revision of the World Health
Organization classification of tumors of hematopoietic and lymphoid tissues is characterized …

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson, E Papaemmanuil… - 2020 - publications.goettingen-research …
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working
Group for the Prognosis of MDS | GRO.publications Import Service | New here? Skip navigation …

[PDF][PDF] SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson, E Papaemmanuil… - 2020 - repository.ubn.ru.nl
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …

[HTML][HTML] SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, K Stevenson, E Papaemmanuil… - Blood, 2020 - Elsevier
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

L Malcovati, KE Stevenson, E Papaemmanuil… - Blood, 2020 - discovery.dundee.ac.uk
The 2016 revision of the World Health Organization classification of tumors of hematopoietic
and lymphoid tissues is characterized by a closer integration of morphology and molecular …